table of content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2022-2027)
1.4.2 East Asia Market States and Outlook (2022-2027)
1.4.3 Europe Market States and Outlook (2022-2027)
1.4.4 South Asia Market States and Outlook (2022-2027)
1.4.5 Southeast Asia Market States and Outlook (2022-2027)
1.4.6 Middle East Market States and Outlook (2022-2027)
1.4.7 Africa Market States and Outlook (2022-2027)
1.4.8 Oceania Market States and Outlook (2022-2027)
1.4.9 South America Market States and Outlook (2022-2027)
1.5 Global Biopharmaceuticals Contract Manufacturing Market Size Analysis from 2022 to 2027
1.5.1 Global Biopharmaceuticals Contract Manufacturing Market Size Analysis from 2022 to 2027 by Consumption Volume
1.5.2 Global Biopharmaceuticals Contract Manufacturing Market Size Analysis from 2022 to 2027 by Value
1.5.3 Global Biopharmaceuticals Contract Manufacturing Price Trends Analysis from 2022 to 2027
1.6 COVID-19 Outbreak: Biopharmaceuticals Contract Manufacturing Industry Impact
Chapter 2 Global Biopharmaceuticals Contract Manufacturing Competition by Types, Applications, and Top Regions and Countries
2.1 Global Biopharmaceuticals Contract Manufacturing (Volume and Value) by Type
2.1.1 Global Biopharmaceuticals Contract Manufacturing Consumption and Market Share by Type (2016-2021)
2.1.2 Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Type (2016-2021)
2.2 Global Biopharmaceuticals Contract Manufacturing (Volume and Value) by Application
2.2.1 Global Biopharmaceuticals Contract Manufacturing Consumption and Market Share by Application (2016-2021)
2.2.2 Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Application (2016-2021)
2.3 Global Biopharmaceuticals Contract Manufacturing (Volume and Value) by Regions
2.3.1 Global Biopharmaceuticals Contract Manufacturing Consumption and Market Share by Regions (2016-2021)
2.3.2 Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Regions (2016-2021)
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2016-2021 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2016-2021 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
Chapter 4 Global Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import by Regions (2016-2021)
4.1 Global Biopharmaceuticals Contract Manufacturing Consumption by Regions (2016-2021)
4.2 North America Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.3 East Asia Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.4 Europe Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.5 South Asia Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.6 Southeast Asia Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.7 Middle East Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.8 Africa Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.9 Oceania Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
4.10 South America Biopharmaceuticals Contract Manufacturing Sales, Consumption, Export, Import (2016-2021)
Chapter 5 North America Biopharmaceuticals Contract Manufacturing Market Analysis
5.1 North America Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
5.1.1 North America Biopharmaceuticals Contract Manufacturing Market Under COVID-19
5.2 North America Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
5.3 North America Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
5.4 North America Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
5.4.1 United States Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
5.4.2 Canada Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
5.4.3 Mexico Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 6 East Asia Biopharmaceuticals Contract Manufacturing Market Analysis
6.1 East Asia Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
6.1.1 East Asia Biopharmaceuticals Contract Manufacturing Market Under COVID-19
6.2 East Asia Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
6.3 East Asia Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
6.4 East Asia Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
6.4.1 China Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
6.4.2 Japan Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
6.4.3 South Korea Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 7 Europe Biopharmaceuticals Contract Manufacturing Market Analysis
7.1 Europe Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
7.1.1 Europe Biopharmaceuticals Contract Manufacturing Market Under COVID-19
7.2 Europe Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
7.3 Europe Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
7.4 Europe Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
7.4.1 Germany Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.2 UK Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.3 France Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.4 Italy Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.5 Russia Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.6 Spain Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.7 Netherlands Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.8 Switzerland Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
7.4.9 Poland Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 8 South Asia Biopharmaceuticals Contract Manufacturing Market Analysis
8.1 South Asia Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
8.1.1 South Asia Biopharmaceuticals Contract Manufacturing Market Under COVID-19
8.2 South Asia Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
8.3 South Asia Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
8.4 South Asia Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
8.4.1 India Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
8.4.2 Pakistan Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
8.4.3 Bangladesh Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 9 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Analysis
9.1 Southeast Asia Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
9.1.1 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Under COVID-19
9.2 Southeast Asia Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
9.3 Southeast Asia Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
9.4 Southeast Asia Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
9.4.1 Indonesia Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
9.4.2 Thailand Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
9.4.3 Singapore Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
9.4.4 Malaysia Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
9.4.5 Philippines Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
9.4.6 Vietnam Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
9.4.7 Myanmar Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 10 Middle East Biopharmaceuticals Contract Manufacturing Market Analysis
10.1 Middle East Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
10.1.1 Middle East Biopharmaceuticals Contract Manufacturing Market Under COVID-19
10.2 Middle East Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
10.3 Middle East Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
10.4 Middle East Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
10.4.1 Turkey Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.2 Saudi Arabia Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.3 Iran Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.4 United Arab Emirates Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.5 Israel Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.6 Iraq Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.7 Qatar Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.8 Kuwait Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
10.4.9 Oman Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 11 Africa Biopharmaceuticals Contract Manufacturing Market Analysis
11.1 Africa Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
11.1.1 Africa Biopharmaceuticals Contract Manufacturing Market Under COVID-19
11.2 Africa Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
11.3 Africa Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
11.4 Africa Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
11.4.1 Nigeria Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
11.4.2 South Africa Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
11.4.3 Egypt Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
11.4.4 Algeria Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
11.4.5 Morocco Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 12 Oceania Biopharmaceuticals Contract Manufacturing Market Analysis
12.1 Oceania Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
12.2 Oceania Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
12.3 Oceania Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
12.4 Oceania Biopharmaceuticals Contract Manufacturing Consumption by Top Countries
12.4.1 Australia Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
12.4.2 New Zealand Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 13 South America Biopharmaceuticals Contract Manufacturing Market Analysis
13.1 South America Biopharmaceuticals Contract Manufacturing Consumption and Value Analysis
13.1.1 South America Biopharmaceuticals Contract Manufacturing Market Under COVID-19
13.2 South America Biopharmaceuticals Contract Manufacturing Consumption Volume by Types
13.3 South America Biopharmaceuticals Contract Manufacturing Consumption Structure by Application
13.4 South America Biopharmaceuticals Contract Manufacturing Consumption Volume by Major Countries
13.4.1 Brazil Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.2 Argentina Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.3 Columbia Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.4 Chile Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.5 Venezuela Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.6 Peru Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.7 Puerto Rico Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
13.4.8 Ecuador Biopharmaceuticals Contract Manufacturing Consumption Volume from 2016 to 2021
Chapter 14 Company Profiles and Key Figures in Biopharmaceuticals Contract Manufacturing Business
14.1 Boehringer Ingelheim
14.1.1 Boehringer Ingelheim Company Profile
14.1.2 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product Specification
14.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.2 Lonza Group AG
14.2.1 Lonza Group AG Company Profile
14.2.2 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product Specification
14.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.3 Inno Biologics Sdn Bhd
14.3.1 Inno Biologics Sdn Bhd Company Profile
14.3.2 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product Specification
14.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.4 Rentschler Biopharma
14.4.1 Rentschler Biopharma Company Profile
14.4.2 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product Specification
14.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.5 JRS Pharma
14.5.1 JRS Pharma Company Profile
14.5.2 JRS Pharma Biopharmaceuticals Contract Manufacturing Product Specification
14.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.6 AGC Biologics
14.6.1 AGC Biologics Company Profile
14.6.2 AGC Biologics Biopharmaceuticals Contract Manufacturing Product Specification
14.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.7 ProBioGen
14.7.1 ProBioGen Company Profile
14.7.2 ProBioGen Biopharmaceuticals Contract Manufacturing Product Specification
14.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.8 FUJIFILM Diosynth Biotechnologies
14.8.1 FUJIFILM Diosynth Biotechnologies Company Profile
14.8.2 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product Specification
14.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.9 Toyobo Co., Ltd.
14.9.1 Toyobo Co., Ltd. Company Profile
14.9.2 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Specification
14.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.10 Samsung Biologics
14.10.1 Samsung Biologics Company Profile
14.10.2 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product Specification
14.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.11 Thermo Fisher Scientific
14.11.1 Thermo Fisher Scientific Company Profile
14.11.2 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product Specification
14.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.12 Binex Co., Ltd.
14.12.1 Binex Co., Ltd. Company Profile
14.12.2 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product Specification
14.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.13 WuXi Biologics
14.13.1 WuXi Biologics Company Profile
14.13.2 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product Specification
14.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
14.14 AbbVie, Inc.
14.14.1 AbbVie, Inc. Company Profile
14.14.2 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product Specification
14.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Production Capacity, Revenue, Price and Gross Margin (2016-2021)
Chapter 15 Global Biopharmaceuticals Contract Manufacturing Market Forecast (2022-2027)
15.1 Global Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Price Forecast (2022-2027)
15.1.1 Global Biopharmaceuticals Contract Manufacturing Consumption Volume and Growth Rate Forecast (2022-2027)
15.1.2 Global Biopharmaceuticals Contract Manufacturing Value and Growth Rate Forecast (2022-2027)
15.2 Global Biopharmaceuticals Contract Manufacturing Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)
15.2.1 Global Biopharmaceuticals Contract Manufacturing Consumption Volume and Growth Rate Forecast by Regions (2022-2027)
15.2.2 Global Biopharmaceuticals Contract Manufacturing Value and Growth Rate Forecast by Regions (2022-2027)
15.2.3 North America Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.4 East Asia Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.5 Europe Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.6 South Asia Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.7 Southeast Asia Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.8 Middle East Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.9 Africa Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.10 Oceania Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.2.11 South America Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)
15.3 Global Biopharmaceuticals Contract Manufacturing Consumption Volume, Revenue and Price Forecast by Type (2022-2027)
15.3.1 Global Biopharmaceuticals Contract Manufacturing Consumption Forecast by Type (2022-2027)
15.3.2 Global Biopharmaceuticals Contract Manufacturing Revenue Forecast by Type (2022-2027)
15.3.3 Global Biopharmaceuticals Contract Manufacturing Price Forecast by Type (2022-2027)
15.4 Global Biopharmaceuticals Contract Manufacturing Consumption Volume Forecast by Application (2022-2027)
15.5 Biopharmaceuticals Contract Manufacturing Market Forecast Under COVID-19
Chapter 16 Conclusions
Research Methodology
